secwatch.observer — SEC 8-K summary
======================================

Issuer:     Singular Genomics Systems, Inc. (—)
CIK:        0001850906
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0000950170-24-005804
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Singular Genomics transfers to Nasdaq Capital Market; gets 180 days to regain $1 bid price
--------------------------------------------------------------------------------

- Approval received Jan 16, 2024; transfer effective Jan 18, 2024, to Nasdaq Capital Market under symbol OMIC.
- Company was non-compliant with Nasdaq's $1.00 minimum bid price requirement since July 17, 2023.
- Granted 180-day compliance period until July 15, 2024; must close at $1.00+ for 10 consecutive business days.
- If compliance not achieved, Nasdaq will delist; company may effect reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850906/000095017024005804/0000950170-24-005804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850906/000095017024005804/omic-20240116.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-005804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer